Lemaitre Vascular (LMAT) Change in Receivables (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Change in Receivables of $2.5 million for Q1 2026, down 46.29% year-over-year from $4.6 million in Q1 2025, and up 60.69% quarter-over-quarter from $1.5 million in Q4 2025.
Lemaitre Vascular (LMAT) Change in Receivables (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Change in Receivables for 17 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 46.29% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $809000.0 (down 84.7% YoY), while the FY2025 annual figure was $2.9 million, down 54.08% from the prior year.
- Change in Receivables climbed to $2.5 million in Q1 2026 per LMAT's latest filing, from $1.5 million in the prior quarter.
- Across five years, Change in Receivables topped out at $5.8 million in Q1 2024 and bottomed at -$3.9 million in Q3 2025.
- Historically, Change in Receivables has averaged $1.1 million across 5 years, with a median of $997000.0 in 2023.
- Annual changes were most pronounced in 2022 — Change in Receivables jumped 357.0% — and 2025, when it sank 513.59%.
- Lemaitre Vascular's Change in Receivables stood at $1.8 million in 2022, then tumbled by 41.09% to $1.1 million in 2023, then slumped by 196.12% to -$1.0 million in 2024, then jumped by 251.82% to $1.5 million in 2025, then soared by 60.69% to $2.5 million in 2026.
- Business Quant data shows LMAT's Change in Receivables at $2.5 million in Q1 2026, $1.5 million in Q4 2025, and -$3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 74.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 37.21 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 252.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 156.00 Mn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 396,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 396,000.00 |
| Jun 30, 2026 | 396,000.00 |
| Mar 31, 2026 | 2.48 Mn |
| Mar 31, 2026 | 2.48 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | -3.90 Mn |
| Sep 30, 2025 | -3.90 Mn |
| Jun 30, 2025 | 680,000.00 |
| Jun 30, 2025 | 680,000.00 |
| Mar 31, 2025 | 4.62 Mn |
| Mar 31, 2025 | 4.62 Mn |
| Dec 31, 2024 | -1.02 Mn |
| Dec 31, 2024 | -1.02 Mn |
| Sep 30, 2024 | 942,000.00 |
| Sep 30, 2024 | 942,000.00 |
| Jun 30, 2024 | 743,000.00 |
| Jun 30, 2024 | 743,000.00 |
| Mar 31, 2024 | 5.75 Mn |
| Mar 31, 2024 | 5.75 Mn |